GI Flashcards
H2 Antagonists: Mechanism of Action
Block histamine receptor on parietal cells. Usually histamine activates the proton pump. There are alternate mechanisms so they are not as completely suppressive as PPIs
H2 Antagonists: Indications
PUD, GORD, Dyspepsia
H2 Antagonists: Side effects
Generally well tolerated, diarrhoea, constipation, headaches
H2 Antagonists: Interactions and Warnings
No major interactions
Really excreted, so reduce dose in renal impairment
Can mask signs of gastric cancer
H2 Antagonists: Prescribing
Short term use = OTC
No monitoring
Therapy is guided by symptoms
They have generally been superseded by PPIs, but they do have a faster onset
PPI: Mechanism of Action
Irreversibly inhibit H+/K+ATPase in parietal cells so reduced acid production
PPI: Indications
First line therapy for PUD, GORD, dyspepsia
H.Pylori eradication, as part of triple therapy
PPI: Side Effects
GI Disturbance, headaches, some evidence of increases C.diff risk
PPI: Interactions and Warnings
Omeprazole can decrease the efficacy of clopidogrel. Other PPIs have less of an effect.
They can mask the symptoms of GI cancer
Can increase the risk of osteoporosis
PPI: Prescribing
Oral or injectable available
Mesalazine: Mechanism of Action
It is an aminosalycilate drug. It acts be releasing 5-ASA. Its precise mechanism is unknown, but it acts locally on the gut and has anti-inflammatory and immunosuppressive effects.
Mesalazine: Indications
Mild to moderate UC (First line drug)
Mesalazine: Side Effects
Nausea, dyspepsia, headache
Rare but serious: renal impairment, leukopenia, thrombocytopenia
Mesalazine: Interactions and Warnings
Tablets with a pH sensitive coating may be affected by changes in gastric pH
ASPIRIN ALLERGY!
Mesalazine: Prescribing
Oral or suppository
Renal function should be checked for safety
Efficacy is guided by symptoms